Vanta Bioscience Ltd

VANTABIO Share Price

BSE

₹17.758.50% (+1.39)

Health Care

Labs & Life Sciences Services

Smallcap

With a market cap of ₹12 cr, stock is ranked 4,734

High Risk

Stock is 6.88x as volatile as Nifty

VANTABIO Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Low

Profitability and efficiency haven't been upto the mark

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health Care

Labs & Life Sciences Services

Smallcap

With a market cap of ₹12 cr, stock is ranked 4,734

High Risk

Stock is 6.88x as volatile as Nifty

VANTABIO Performance & Key Metrics

No LabelNo Label	PB RatioPB Ratio	Dividend YieldDiv. Yield
—	3.28	—

Sector PESector PE	Sector PBSector PB	Sector Div YldSctr Div Yld
35.10	5.54	0.61%

VANTABIO Analyst Ratings & Forecast

—

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

VANTABIO Company Profile

The company is a preclinical contract research company. It provides preclinical safety assessment services, assessment services for evaluating the safety of the active pharmaceutical ingredients (API), etc.

VANTABIO Similar Stocks (Peers)

Compare with peers Compare with peers

VANTABIO Similar Stocks (Peers)

Compare with peers Compare with peers

Divi's Laboratories Ltd

DIVISLAB

PE Ratio

72.36

1Y Return

4.77%

Buy Reco %

62.50

Syngene International Ltd

SYNGENE

PE Ratio

33.02

1Y Return

41.12%

Buy Reco %

66.67

Aarti Pharmalabs Ltd

AARTIPHARM

PE Ratio

21.54

1Y Return

16.15%

Buy Reco %

0.00

Dishman Carbogen Amcis Ltd

DCAL

PE Ratio

775.79

1Y Return

31.08%

Buy Reco %

0.00

Vimta Labs Ltd

VIMTALABS

PE Ratio

27.78

1Y Return

23.95%

Buy Reco %

0.00

Compare with Peers

VANTABIO Forecast

VANTABIO Forecasts

VANTABIO

Income

Balance Sheet

Cash Flow

Financial Year		FY 2018		FY 2019		FY 2020		FY 2021		FY 2022	FY 2023	FY 2024	FY 2025	TTM
Total Revenue	4.04	12.65	14.25	10.07	10.11	6.97	9.83	2.07	0.00
Raw Materials	2.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Power & Fuel Cost		0.98	1.04	0.54	0.55	0.75	1.01	0.43
Employee Cost		2.90	3.93	2.51	2.67	3.46	3.79	1.76
Selling & Administrative Expenses		3.23	3.30	1.94	2.00	3.08	2.53	2.26
Operating & Other expenses		2.04	1.50	1.10	1.00	1.38	1.08	1.77
EBITDA	1.08	3.50	4.48	3.98	3.89	-1.70	1.42	-4.15	0.00
Depreciation/Amortization	0.57	0.71	1.19	1.25	1.32	2.67	4.50	4.42	0.00
PBIT	0.51	2.79	3.29	2.73	2.57	-4.37	-3.08	-8.57	0.00
Interest & Other Items	0.20	1.69	1.95	2.14	2.35	5.89	5.75	4.07	0.00
PBT	0.31	1.10	1.34	0.59	0.22	-10.26	-8.83	-12.64	0.00
Taxes & Other Items	0.29	0.40	0.34	0.14	0.14	-3.78	-6.51	-7.86	0.00
Net Income	0.02	0.70	1.00	0.45	0.08	-6.48	-2.32	-4.78	0.00
EPS	0.05	1.11	1.58	0.71	0.13	-10.27	-3.68	-7.57	0.00
DPS	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout ratio	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

VANTABIO Income Statement

Quarter		dec 2021		dec 2022	mar 2023
Total Revenue	0.00	2.83	1.29
Operating & Other expenses	0.00	3.37	1.93
EBITDA	0.00	-0.54	-0.64
Depreciation/Amortization	0.00	1.31	0.05
PBIT	0.00	-1.85	-0.69
Interest & Other Items	0.00	2.48	0.92
PBT	0.00	-4.33	-1.61
Taxes & Other Items	0.38	0.09	-0.01
Net Income	-0.38	-4.42	-1.60
EPS	0.00	-4.06	0.00

Financial Year		FY 2019		FY 2020		FY 2021		FY 2022	FY 2023	FY 2024	FY 2025
Cash from Operating Activities	-1.04	2.34	6.97	5.28	-0.63	2.68	-2.41
Cash from Investing Activities	-5.73	-7.59	-22.30	-17.24	-5.91	-3.31	-6.69
Cash from Financing Activities	9.94	2.17	17.78	9.53	6.41	0.69	9.16
Net Change in Cash	+3.17	-3.08	+2.45	-2.43	-0.13	+0.06	+0.06
Changes in Working Capital	-4.54	-2.14	+3.01	+1.39	+1.09	+1.32	+1.74
Capital Expenditures	2.48	0.35	0.86	0.33	28.69	3.40	6.69
Free Cash Flow	-3.52	1.99	6.11	4.95	-29.32	-0.72	-9.10

VANTABIO Company Updates

FY 2025FY 2025

Annual report

PDF

FY 2024FY 2024

Annual report

PDF

FY 2023FY 2023

Annual report

PDF

FY 2022FY 2022

Annual report

PDF

FY 2021FY 2021

Annual report

PDF

FY 2020FY 2020

Annual report

PDF

FY 2019FY 2019

Annual report

PDF

FY 2018FY 2018

Annual report

PDF

VANTABIO Stock Peers

VANTABIO Past Performance & Peer Comparison

Comparing 3 stocks from
Health CareLabs & Life Sciences Services

Valuation

Technical

Forecast

Compare valuation on Screener

Stock	PE RatioPE Ratio	PB RatioPB Ratio	Div. YieldDividend Yield
Vanta Bioscience Ltd	-2.60	3.28	—
Divi's Laboratories Ltd	72.36	10.59	0.50%
Syngene International Ltd	33.02	3.47	0.31%
Aarti Pharmalabs Ltd	21.54	2.95	0.77%

VANTABIO Stock Price Comparison

Compare VANTABIO with any stock or ETF

VANTABIO

VANTABIO Holdings

VANTABIO Shareholdings

VANTABIO Promoter Holdings Trend

VANTABIO Institutional Holdings Trend

VANTABIO Shareholding Pattern

VANTABIO Shareholding History

Foreign Institutions

VANTABIO Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing VANTABIO stock

Looks like this stock is not in any smallcase yet.

VANTABIO Events

VANTABIO Dividend Trend

Dividends

Corp. Actions

Announcements

Legal Orders

VANTABIO Dividend Trend

VANTABIO Dividends

Hmm, looks like data is unavailable here. Please come back after some time

VANTABIO Corp. Actions

Hmm, looks like data is unavailable here. Please come back after some time

No upcoming announcements are available

Company Update

Announced OnMar 11, 2026

Vanta Bioscience Ltd - 540729 - Clarific

Vanta Bioscience Ltd - 540729 - Clarific Download

Link

Download

Announced On

Mar 11, 2026

Company Update

Announced OnFeb 25, 2026

Vanta Bioscience Ltd - 540729 - Clarific

Link

—

Announced On

Feb 25, 2026

VANTABIO Legal Orders

Hmm, looks like data is unavailable here. Please come back after some time

VANTABIO Stock News & Opinions

Corporate

Vanta Bioscience to discuss results

Vanta Bioscience will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live

Corporate

Vanta Bioscience to conduct AGM

Vanta Bioscience announced that the 9th Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live

Corporate

Vanta Bioscience revises board meeting date

Vanta Bioscience has revised the meeting of the Board of Directors which was scheduled to be held on 29 July 2025. The meeting will now be held on 1 August 2025.Powered by Capital Market - Live

7 months agoCapital Market - Live

Corporate

Vanta Bioscience revises board meeting date

Vanta Bioscience has revised the meeting of the Board of Directors which was scheduled to be held on 24 July 2025. The meeting will now be held on 29 July 2025.Powered by Capital Market - Live

7 months agoCapital Market - Live

Corporate

Vanta Bioscience revises board meeting date

Vanta Bioscience has revised the meeting of the Board of Directors which was scheduled to be held on 19 July 2025. The meeting will now be held on 24 July 2025.Powered by Capital Market - Live

8 months agoCapital Market - Live

Corporate

Vanta Bioscience schedules board meeting

Vanta Bioscience will hold a meeting of the Board of Directors of the Company on 19 July 2025.Powered by Capital Market - Live

8 months agoCapital Market - Live

Corporate

Vanta Bioscience cancels board meeting

Vanta Bioscience has cancelled the board meeting which was scheduled to be held on 30 May 2025.Powered by Capital Market - Live

9 months agoCapital Market - Live

Corporate

Vanta Bioscience schedules board meeting

Vanta Bioscience will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live

9 months agoCapital Market - Live

Corporate

Vanta Bioscience schedules EGM

Vanta Bioscience announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 4 January 2025.Powered by Capital Market - Live

1 year agoCapital Market - Live

Corporate

Vanta Bioscience to hold board meeting

Vanta Bioscience will hold a meeting of the Board of Directors of the Company on 6 December 2024Powered by Capital Market - Live

1 year agoCapital Market - Live

Frequently asked questions

What is the share price of Vanta Bioscience Ltd (VANTABIO) today?
The share price of VANTABIO as on 23rd March 2026 is ₹17.75. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.
What is the return on Vanta Bioscience Ltd (VANTABIO) share?
The past returns of Vanta Bioscience Ltd (VANTABIO) share are
- Past 1 week: 2.94%
- Past 1 month: -20.99%
- Past 3 months: -18.53%
- Past 6 months: -36.74%
- Past 1 year: -41.36%
- Past 3 years: -76.08%
- Past 5 years: -91.12%
What are the peers or stocks similar to Vanta Bioscience Ltd (VANTABIO)?
The peers or stocks similar to Vanta Bioscience Ltd (VANTABIO) include:
What is the market cap of Vanta Bioscience Ltd (VANTABIO) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Vanta Bioscience Ltd (VANTABIO) is ₹12.41 Cr as of 23rd March 2026.
What is the 52 week high and low of Vanta Bioscience Ltd (VANTABIO) share?
The 52-week high of Vanta Bioscience Ltd (VANTABIO) is ₹31.33 and the 52-week low is ₹15.
What is the PE and PB ratio of Vanta Bioscience Ltd (VANTABIO) stock?
The P/E (price-to-earnings) ratio of Vanta Bioscience Ltd (VANTABIO) is -2.60. The P/B (price-to-book) ratio is 3.28.
Which sector does Vanta Bioscience Ltd (VANTABIO) belong to?
Vanta Bioscience Ltd (VANTABIO) belongs to the Health Care sector & Labs & Life Sciences Services sub-sector.
How to buy Vanta Bioscience Ltd (VANTABIO) shares?
You can directly buy Vanta Bioscience Ltd (VANTABIO) shares on Tickertape. Simply sign up, connect your demat account and place your order.

Stock	VolatilityVolatility	RSI–14DRSI – 14D	Price Mom RankPrice Momentum Rank
Vanta Bioscience Ltd	88.35%	22.39	Pro
Divi's Laboratories Ltd	25.64%	19.51
Syngene International Ltd	30.71%	40.81
Aarti Pharmalabs Ltd	43.58%	30.89

Vanta Bioscience Ltd

VANTABIO Share Price

VANTABIO Stock Scorecard

VANTABIO Performance & Key Metrics

VANTABIO Performance & Key Metrics

VANTABIO Analyst Ratings & Forecast

Price Upside

Earnings Growth

Rev. Growth

VANTABIO Company Profile

VANTABIO Similar Stocks (Peers)

VANTABIO Similar Stocks (Peers)

VANTABIO Forecast

VANTABIO Forecasts

VANTABIO